Stay updated with breaking news from Pharma Vision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The growth of the pharma sector has been nothing short of tremendous. With this momentum and with the support of public and private partnerships, India has all the capabilities to reach $120-$130 billion by 2030
Union Minister Mansukh Mandaviya on Saturday exhorted the champions, leaders of the Pharmaceutical Industry and discussed the roadmap for the Indian pharmaceutical sector.
Let us move from 'Volume' to 'Value' leadership to capture global pharmaceutical market, said Union Health Minister Mansukh said on Saturday.He told the leaders of Pharma industry that it is time to accumulate knowledge from global best ...
INever content with the role as a mere financial investor, Martin Ebner is admired as a financier and feared as a corporate raider. His career was unparalleled in Switzerland.
Is it time to rethink PSE policy? × Yes, especially in the pharma space where public sector units have the infrastructure, manpower and technical expertise Recently, the government said that it will be using three public sector enterprises for manufacturing Covaxin to augment the manufacturing capacity under Mission COVID Suraksha. These were Haffkine Biopharmaceutical Corporation Ltd, a State public sector enterprise (PSE) under the Maharashtra government; Indian Immunologicals Ltd (IIL), Hyderabad — a facility under National Dairy Development Board; and Bharat Immunologicals and Biologi...